CDXI
CARDAX INC
stock OTC

cardax (otcqb: cdxi) is developing proprietary astaxanthin therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles. introduction cardax is a development stage life sciences company that devotes substantially all of its efforts to developing nutraceutical and pharmaceutical products that provide the anti-inflammatory benefits of steroids or nsaids, but with exceptional safety profiles, as conferred by u.s. food and drug administration ("fda") generally recognized as safe ("gras") designation at certain doses. cardax is preparing proprietary nature-identical products and related derivatives by total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated, including, but not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate